NCT06322095 2024-10-01
A Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors
Suzhou Genhouse Bio Co., Ltd.
Phase 2 Unknown
Clinical Trials
60 trialsNCT06136065 2024-06-04
FAPI
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Unknown
NCT06262581 2024-02-16
Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery
Sun Yat-sen University
Phase 2 Unknown
NCT04983745 2023-12-21
DIDO
West Cancer Center
Phase 2 Unknown
NCT06022289 2023-09-01
Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors
Tianjin Medical University Second Hospital
Phase 2 Unknown
NCT03810339 2023-06-27
Toripalimab as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors
Sun Yat-sen University
Phase 2 Unknown
NCT04940637 2023-05-12
UNITO-001
University of Turin, Italy
Phase 2 Unknown
NCT05815290 2023-04-18
Cadonilimab in Locally Advanced MSI-H/dMMR Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT03654833 2023-03-14
MiST
University of Leicester
Phase 2 Unknown
NCT05429866 2023-03-08
Immunological Variables Associated to ICI Toxicity in Cancer Patients
Jules Bordet Institute
Phase 2 Unknown
NCT05372120 2023-01-04
A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2 Unknown
NCT05214976 2022-12-22
A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT02436733 2022-11-07
Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Unknown
NCT05528406 2022-09-06
A Phase II Clinical Trial to Evaluate HLX208 in Advanced Solid Tumor Patients With BRAF V600 Mutation
Shanghai Henlius Biotech
Phase 2 Unknown
NCT05512780 2022-08-23
Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage â…¡-â…¢ HR-positive/HER2-negative Breast Cancer
Hebei Medical University Fourth Hospital
Phase 2 Unknown
NCT03491345 2022-08-09
K-Basket, Avelumab, Biomarker-driven, Advanced Solid Tumor
Yonsei University
Phase 2 Unknown
NCT04892498 2022-08-09
Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0)
Second Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT05349409 2022-06-30
A Trial of the Combination of SHR-A1811 and Fluzoparib in HER2-Expressing Cancers
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2 Unknown
NCT04013334 2022-06-16
MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma
Momotaro-Gene Inc.
Phase 2 Unknown
NCT05218148 2022-04-06
SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma
ChineseAMS
Phase 2 Unknown
NCT05274191 2022-03-10
An Exploratory Basket Study of Pyrotinib Maleate Tablets in HER2 Mutated or Amplified of Metastatic Solid Tumors
Zhongshan Hospital Xiamen University
Phase 2 Unknown
NCT05254665 2022-02-24
A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 2 Unknown
NCT04282278 2021-12-10
Study of Anti-PD-1 Antibody Multimodal Combination as First-line Treatment on Time Window of Advanced Solid Tumor
Hebei Medical University Fourth Hospital
Phase 2 Unknown
NCT05097781 2021-10-28
Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients
Ruijin Hospital
Phase 2 Unknown
NCT05035381 2021-09-05
PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT04990271 2021-08-04
A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of Retinoblastoma
Chengdu Kanghong Biotech Co., Ltd.
Phase 2 Unknown
NCT04869475 2021-05-13
Arsenic Trioxide in Refractory Solid Tumors With Rescuable p53 Mutation
Ruijin Hospital
Phase 2 Unknown
NCT04832204 2021-04-05
Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases
Beijing Hospital
Phase 2 Unknown
NCT03704246 2021-03-04
Recombinant Human Anti-PD-1 Monoclonal Antibody HX008 Injection for the Treatment of Advanced Solid Tumors
Taizhou Hanzhong biomedical co. LTD
Phase 2 Unknown
NCT04713761 2021-01-26
Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Unknown
NCT04569916 2020-09-30
Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Unknown
NCT04462809 2020-07-09
TALAMESO
Hospices Civils de Lyon
Phase 2 Unknown
NCT02638428 2020-03-19
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
Samsung Medical Center
Phase 2 Unknown
NCT04291248 2020-03-02
A Study of Anlotinib Combined With AK105 Injection in Subjects With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Advanced Solid Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Unknown
NCT04179656 2019-11-27
The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor
Tianjin Medical University Second Hospital
Phase 2 Unknown
NCT02349958 2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2 Unknown
NCT02787876 2018-09-18
Pegteograstim in Children With Solid Tumors
Samsung Medical Center
Phase 2 Unknown
NCT02755675 2016-11-21
uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung
Rigshospitalet, Denmark
Phase 2 Unknown
NCT02588131 2015-10-27
A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)
Italian Network for Tumor Biotherapy Foundation
Phase 2 Unknown
NCT02497053 2015-07-14
Four Versus Six Cycles of Pemetrexed/Platinum for MPM
Ain Shams University
Phase 2 Unknown
NCT02339753 2015-01-16
Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation
The Korean Society of Pediatric Hematology Oncology
Phase 2 Unknown
NCT01279967 2014-11-20
ADAM
Barts & The London NHS Trust
Phase 2 Unknown
NCT02255292 2014-10-02
A Study: Pure CBD as Single-agent for Solid Tumor.
Hadassah Medical Organization
Phase 2 Unknown
NCT01899066 2014-05-13
Efficacy Study of Lucentis in the Treatment of Retinoblastoma
Sun Yat-sen University
Phase 2 Unknown
NCT02045719 2014-01-27
cat´sclaw
Faculdade de Medicina do ABC
Phase 2 Unknown
NCT00024271 2014-01-06
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00030459 2013-08-07
Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01558453 2013-03-26
Oxaliplatin for Children With Solid Tumors
Hospital Santa Marcelina
Phase 2 Unknown
NCT01569919 2013-03-12
SKOPOS
Wales Cancer Trials Unit
Phase 2 Unknown
NCT01655888 2012-08-02
The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese
Phase 2 Unknown